Stocks
HCA Healthcare Financial Statements (HCA) |
||||||||||
| HCA Healthcaresmart-lab.ru | % | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 02.08.2023 | 26.10.2023 | 16.02.2024 | 31.03.2024 | 02.05.2024 | 02.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 15 861 | 16 213 | 17 303 | 17 339 | 17 339 | 68 194 | |||
| Operating Income, bln rub | 2 293 | 2 111 | 2 801 | 2 560 | 2 560 | 10 032 | ||||
| EBITDA, bln rub | ? | 3 056 | 2 880 | 3 618 | 3 355 | 3 355 | 13 208 | |||
| Net profit, bln rub | ? | 1 193 | 1 079 | 1 607 | 1 591 | 1 591 | 5 868 | |||
| OCF, bln rub | ? | 2 475 | 2 479 | 2 674 | 2 469 | 2 469 | 10 091 | |||
| CAPEX, bln rub | ? | 1 241 | 1 147 | 1 159 | 1 118 | 1 118 | 4 542 | |||
| FCF, bln rub | ? | 1 234 | 1 332 | 1 515 | 1 351 | 1 351 | 5 549 | |||
| Dividend payout, bln rub | 164.0 | 162.0 | 160.0 | 185.0 | 185.0 | 692.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 13.7% | 15.0% | 9.96% | 11.6% | 11.6% | 11.8% | ||||
| OPEX, bln rub | 11 083 | 11 704 | 11 918 | 4 202 | 12 108 | 39 932 | ||||
| Cost of production, bln rub | 2 478 | 2 417 | 2 584 | 14 779 | 14 779 | 34 559 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 485.0 | 483.0 | 491.0 | 512.0 | 512.0 | 1 998 | ||||
| Assets, bln rub | 53 594 | 54 589 | 56 211 | 56 962 | 56 962 | 56 962 | ||||
| Net Assets, bln rub | ? | -2 303 | -2 477 | -1 774 | -1 615 | -1 615 | -1 615 | |||
| Debt, bln rub | 40 738 | 41 122 | 41 859 | 42 103 | 42 103 | 42 103 | ||||
| Cash, bln rub | 862.0 | 891.0 | 1 022 | 1 284 | 1 284 | 1 284 | ||||
| Net debt, bln rub | 39 876 | 40 231 | 40 837 | 40 819 | 40 819 | 40 819 | ||||
| Ordinary share price, rub | 303.5 | 246.0 | 270.7 | 333.5 | 333.5 | 228.0 | ||||
| Number of ordinary shares, mln | 274.5 | 271.2 | 265.5 | 268.3 | 263.2 | 263.2 | ||||
| Market cap, bln rub | 83 303 | 66 703 | 71 876 | 89 485 | 87 790 | 60 011 | ||||
| EV, bln rub | ? | 123 179 | 106 934 | 112 713 | 130 304 | 128 609 | 100 830 | |||
| Book value, bln rub | -11 944 | -12 255 | -11 719 | -11 582 | -11 582 | -11 582 | ||||
| EPS, rub | ? | 4.35 | 3.98 | 6.05 | 5.93 | 6.04 | 22.3 | |||
| FCF/share, rub | 4.50 | 4.91 | 5.71 | 5.04 | 5.13 | 21.1 | ||||
| BV/share, rub | -43.5 | -45.2 | -44.1 | -43.2 | -44.0 | -44.0 | ||||
| EBITDA margin, % | ? | 19.3% | 17.8% | 20.9% | 19.3% | 19.3% | 19.4% | |||
| Net margin, % | ? | 7.52% | 6.66% | 9.29% | 9.18% | 9.18% | 8.60% | |||
| FCF yield, % | ? | 5.92% | 6.56% | 6.52% | 6.07% | 6.19% | 9.25% | |||
| ROE, % | ? | -250.6% | -230.8% | -295.5% | -338.7% | -338.7% | -363.3% | |||
| ROA, % | ? | 10.8% | 10.5% | 9.33% | 9.60% | 9.60% | 10.3% | |||
| P/E | ? | 14.4 | 11.7 | 13.7 | 16.4 | 16.0 | 10.2 | |||
| P/FCF | 16.9 | 15.2 | 15.3 | 16.5 | 16.2 | 10.8 | ||||
| P/S | ? | 1.35 | 1.06 | 1.11 | 1.34 | 1.32 | 0.88 | |||
| P/BV | ? | -6.97 | -5.44 | -6.13 | -7.73 | -7.58 | -5.18 | |||
| EV/EBITDA | ? | 10.0 | 8.70 | 8.86 | 10.1 | 9.96 | 7.63 | |||
| Debt/EBITDA | 3.24 | 3.27 | 3.21 | 3.16 | 3.16 | 3.09 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 7.82% | 7.07% | 6.70% | 6.45% | 6.45% | 6.66% | ||||
| HCA Healthcare shareholders | ||||||||||
